Rydex (Centurion Labs)


Welcome to the PulseAid listing for the Rydex drug offered from Centurion Labs. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Centurion Labs
NON-PROPRIETARY NAME: Brompheniramine Maleate, Codeine Phosphate, Pseudoephedrine Hydrochloride
SUBSTANCE NAME: BROMPHENIRAMINE MALEATE; CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2010-05-14
END MARKETING DATE: 0000-00-00


Rydex HUMAN OTC DRUG Details:

Item DescriptionRydex from Centurion Labs
LABELER NAME: Centurion Labs
DEA SCHEDULE: CV
ACTIVE STRENGTH: 1.33; 6.33; 10(mg/5mL; mg/5mL; mg/5mL)
START MARKETING DATE: 2010-05-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 23359-023_03a0c43b-b783-44a6-a9ff-ad862fb95a82
PRODUCT NDC: 23359-023
APPLICATION NUMBER: part341

Other BROMPHENIRAMINE MALEATE; CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Centurion LabsRydex
Marnel Pharmaceutcals, Inc.Mar-cof BP